What's next for Ebos after the end of that Chemist Warehouse contract

What's next for Ebos after the end of that Chemist Warehouse contract
CEO John Cullity says there isn't double-digit growth to be found in animal or healthcare in Australasia. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the firm must hunt outside of Australasia for double-digit growth. The dual-listed healthcare and pharmaceutical marketer and wholesaler was looking for growth outside its traditional powerhouse pharmaceutical business, Cullity said. He said Ebos’s pharmacy business in NZ and Australia was solid and stable but had relatively low growth. “Double-digit growth rates are going to be very hard, so we need to broaden the group's base of earnings outside of Australia and New Zealand...

More Markets

Receivers launch webpage for potential buyers of Ubco
Markets

Receivers launch webpage for potential buyers of Ubco

'Savvy investors' invited to secure Kiwi electronic-motorbike 'ingenuity'.

Kawerau plant's fast-track status a boost for Foresta
Markets

Kawerau plant's fast-track status a boost for Foresta

The company has successfully raised funds but has yet to start construction.

Investment heaven: public assets and private investors
Infrastructure

Investment heaven: public assets and private investors

Central and local government have billions in assets and need cash. Enter private money?

Popeyes gives KFC some crispy competition
Retail

Popeyes gives KFC some crispy competition

Tahua Group is going after Restaurant Brands’ golden goose (chicken).